These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27488528)

  • 1. Splenic Marginal Zone Granulocytes Acquire an Accentuated Neutrophil B-Cell Helper Phenotype in Chronic Lymphocytic Leukemia.
    Gätjen M; Brand F; Grau M; Gerlach K; Kettritz R; Westermann J; Anagnostopoulos I; Lenz P; Lenz G; Höpken UE; Rehm A
    Cancer Res; 2016 Sep; 76(18):5253-65. PubMed ID: 27488528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretory IgM Exacerbates Tumor Progression by Inducing Accumulations of MDSCs in Mice.
    Tang CH; Chang S; Hashimoto A; Chen YJ; Kang CW; Mato AR; Del Valle JR; Gabrilovich DI; Hu CC
    Cancer Immunol Res; 2018 Jun; 6(6):696-710. PubMed ID: 29650518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo.
    Hanna BS; McClanahan F; Yazdanparast H; Zaborsky N; Kalter V; Rößner PM; Benner A; Dürr C; Egle A; Gribben JG; Lichter P; Seiffert M
    Leukemia; 2016 Mar; 30(3):570-9. PubMed ID: 26522085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Neutrophils in the Pathogenesis of Chronic Lymphocytic Leukemia.
    Wachowska M; Wojciechowska A; Muchowicz A
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to follicular dendritic cells is a pivotal step in murine chronic lymphocytic leukemia B-cell activation and proliferation.
    Heinig K; Gätjen M; Grau M; Stache V; Anagnostopoulos I; Gerlach K; Niesner RA; Cseresnyes Z; Hauser AE; Lenz P; Hehlgans T; Brink R; Westermann J; Dörken B; Lipp M; Lenz G; Rehm A; Höpken UE
    Cancer Discov; 2014 Dec; 4(12):1448-65. PubMed ID: 25252690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of caveolin-1 leads to delayed development of chronic lymphocytic leukemia in Eμ-TCL1 mouse model.
    Shukla A; Cutucache CE; Sutton GL; Pitner MA; Rai K; Rai S; Opavsky R; Swanson PC; Joshi SS
    Exp Hematol; 2016 Jan; 44(1):30-7.e1. PubMed ID: 26435347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond bystanders: Myeloid cells in chronic lymphocytic leukemia.
    Hanna BS; Öztürk S; Seiffert M
    Mol Immunol; 2019 Jun; 110():77-87. PubMed ID: 29173971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the splenic microenvironment in chronic lymphocytic leukemia development in Eµ-TCL1 transgenic mice.
    Collard JP; McKenna MK; Noothi SK; Alhakeem SS; Rivas JR; Rangnekar VM; Muthusamy N; Bondada S
    Leuk Lymphoma; 2022 Aug; 63(8):1810-1822. PubMed ID: 35258388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T cells contribute to the immunosuppressive phenotype of neutrophils in a mouse model of chronic lymphocytic leukemia.
    Goral A; Sledz M; Manda-Handzlik A; Cieloch A; Wojciechowska A; Lachota M; Mroczek A; Demkow U; Zagozdzon R; Matusik K; Wachowska M; Muchowicz A
    Exp Hematol Oncol; 2023 Oct; 12(1):89. PubMed ID: 37817276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic lymphocytic leukemia cells increase neutrophils survival and promote their differentiation into CD16
    Podaza E; Risnik D; Colado A; Elías E; Almejún MB; Fernandez Grecco H; Bezares RF; Borge M; Gamberale R; Giordano M
    Int J Cancer; 2019 Mar; 144(5):1128-1134. PubMed ID: 30178523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTPROt-mediated regulation of p53/Foxm1 suppresses leukemic phenotype in a CLL mouse model.
    Motiwala T; Kutay H; Zanesi N; Frissora FW; Mo X; Muthusamy N; Jacob ST
    Leukemia; 2015 Jun; 29(6):1350-9. PubMed ID: 25482129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of CLL in the TCL1 transgenic mouse model is associated with severe skewing of the T-cell compartment homologous to human CLL.
    Hofbauer JP; Heyder C; Denk U; Kocher T; Holler C; Trapin D; Asslaber D; Tinhofer I; Greil R; Egle A
    Leukemia; 2011 Sep; 25(9):1452-8. PubMed ID: 21606964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic lymphocytic leukemia of Emu-TCL1 transgenic mice undergoes rapid cell turnover that can be offset by extrinsic CD257 to accelerate disease progression.
    Enzler T; Kater AP; Zhang W; Widhopf GF; Chuang HY; Lee J; Avery E; Croce CM; Karin M; Kipps TJ
    Blood; 2009 Nov; 114(20):4469-76. PubMed ID: 19755673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eμ-TCL1 adoptive transfer mouse model of chronic lymphocytic leukemia.
    Fernandez Botana I; Gonder S; Klapp V; Moussay E; Paggetti J
    Methods Cell Biol; 2024; 188():109-129. PubMed ID: 38880520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells.
    Os A; Bürgler S; Ribes AP; Funderud A; Wang D; Thompson KM; Tjønnfjord GE; Bogen B; Munthe LA
    Cell Rep; 2013 Aug; 4(3):566-77. PubMed ID: 23933259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triterpenoids display single agent anti-tumor activity in a transgenic mouse model of chronic lymphocytic leukemia and small B cell lymphoma.
    Kress CL; Konopleva M; Martínez-García V; Krajewska M; Lefebvre S; Hyer ML; McQueen T; Andreeff M; Reed JC; Zapata JM
    PLoS One; 2007 Jun; 2(6):e559. PubMed ID: 17593960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cells and macrophages pursue a common path toward the development and progression of chronic lymphocytic leukemia.
    Galletti G; Caligaris-Cappio F; Bertilaccio MT
    Leukemia; 2016 Dec; 30(12):2293-2301. PubMed ID: 27677742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cd1d regulates B cell development but not B cell accumulation and IL10 production in mice with pathologic CD5(+) B cell expansion.
    Palmer VL; Nganga VK; Rothermund ME; Perry GA; Swanson PC
    BMC Immunol; 2015 Nov; 16():66. PubMed ID: 26537916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia.
    Bresin A; D'Abundo L; Narducci MG; Fiorenza MT; Croce CM; Negrini M; Russo G
    Cell Death Dis; 2016 Jan; 7(1):e2071. PubMed ID: 26821067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The New Zealand black mouse as a model for the development and progression of chronic lymphocytic leukemia.
    Salerno E; Yuan Y; Scaglione BJ; Marti G; Jankovic A; Mazzella F; Laurindo MF; Despres D; Baskar S; Rader C; Raveche E
    Cytometry B Clin Cytom; 2010; 78 Suppl 1(Suppl 1):S98-109. PubMed ID: 20839343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.